Role of Cytokine-Inducible SH2 Domain-Containing (CISH) Protein in the Regulation of Erythropoiesis

被引:2
|
作者
Maymand, Saeed [1 ]
Lakkavaram, Asha L. [1 ]
Naser, Wasan [1 ,2 ]
Rasighaemi, Parisa [1 ]
Dlugolenski, Daniel [1 ]
Liongue, Clifford [1 ,3 ]
Stambas, John [1 ,3 ]
de Koning-Ward, Tania F. [1 ,3 ]
Ward, Alister C. [1 ,3 ]
机构
[1] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia
[2] Univ Baghdad, Coll Sci, Baghdad, Iraq
[3] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic 3216, Australia
关键词
cytokine; CISH; EPO; SOCS; T-CELLS; STAT5; RECEPTOR; PROLIFERATION;
D O I
10.3390/biom13101510
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytokine-inducible SH2 domain-containing (CISH) protein was the first member of the suppressor of cytokine signaling (SOCS) family of negative feedback regulators discovered, being identified in vitro as an inducible inhibitor of erythropoietin (EPO) signaling. However, understanding of the physiological role played by CISH in erythropoiesis has remained limited. To directly assess the function of CISH in this context, mice deficient in CISH were characterized with respect to developmental, steady-state, and EPO-induced erythropoiesis. CISH was strongly expressed in the fetal liver, but CISH knockout (KO) mice showed only minor disruption of primitive erythropoiesis. However, adults exhibited mild macrocytic anemia coincident with subtle perturbation particularly of bone marrow erythropoiesis, with EPO-induced erythropoiesis blunted in the bone marrow of KO mice but enhanced in the spleen. Cish was expressed basally in the bone marrow with induction following EPO stimulation in bone marrow and spleen. Overall, this study indicates that CISH participates in the control of both basal and EPO-induced erythropoiesis in vivo.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Regulation and function of the cytokine-inducible SH-2 domain proteins, CIS and SOCS3, in mammary epithelial cells
    Tonko-Geymayer, S
    Goupille, O
    Tonko, M
    Soratroi, C
    Yoshimura, A
    Streuli, C
    Ziemiecki, A
    Kofler, R
    Doppler, W
    MOLECULAR ENDOCRINOLOGY, 2002, 16 (07) : 1680 - 1695
  • [32] Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
    Sasaki, A
    Yasukawa, H
    Suzuki, A
    Kamizono, S
    Syoda, T
    Kinjyo, I
    Sasaki, M
    Johnston, JA
    Yoshimura, A
    GENES TO CELLS, 1999, 4 (06) : 339 - 351
  • [33] CIS1, a cytokine-inducible SH2 protein, suppresses BCR/ABL-mediated transformation: Involvement of the ubiquitin proteasome pathway
    Tauchi, T
    Yoshimura, A
    Ohyashiki, K
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (03) : 356 - 361
  • [34] Characterization of the roles of SH2 domain-containing proteins in T-lymphocyte activation by using dominant negative SH2 domains
    Northrop, JP
    Pustelnik, MJ
    Lu, AT
    Grove, JR
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (05) : 2255 - 2263
  • [35] Autoantibodies binding to SH2 domain-containing adapter protein B as potential negative predictor for response of rituximab
    Ahmed, D.
    Witte, T.
    Lansche, C.
    Doerner, T.
    Schmidt, R.
    Baerlecken, N.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 24 - 25
  • [36] Aminocholestane and Aminoandrostane Inhibitors of the SH2 Domain-Containing Inositol 5'-Phosphatase (SHIP)
    Pacherille, Angela M.
    Viernes, Dennis R.
    Pedicone, Chiara
    Fernandes, Sandra
    Dungan, Otto M.
    Dormann, Shawn
    Wallach, Daniel R.
    Sudan, Raki
    Brooks, Robbie
    Russo, Christopher M.
    Howard, Kyle T.
    Cosgrove, Michael S.
    Kerr, William G.
    Chisholm, John D.
    CHEMMEDCHEM, 2025,
  • [37] Role of the SH2 domain-containing Phosphatase-1, SHP-1 in Dendritic Cell Activation
    Ramachandran, Indu Rekha
    Levitt, Jonathan Michael
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [38] The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
    Neel, BG
    Gu, HH
    Pao, L
    TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (06) : 284 - 293
  • [39] Role of Tyrosine Phosphatase Inhibitors in Cancer Treatment with Emphasis on SH2 Domain-Containing Tyrosine Phosphatases (SHPs)
    Irandoust, Mahban
    van den Berg, Timo K.
    Kaspers, Gertjan J. L.
    Cloos, Jacqueline
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 212 - 220
  • [40] Identification of SH2 domain-containing proteins and motifs prediction by a deep learning method
    Wu, Duanzhi
    Fang, Xin
    Luan, Kai
    Xu, Qijin
    Lin, Shiqi
    Sun, Shiying
    Yang, Jiaying
    Dong, Bingying
    Manavalan, Balachandran
    Liao, Zhijun
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 162